Inventor · disambiguated record
Kevin Foley
Also filed as: FOLEY KEVIN · FOLEY KEVIN P · FOLEY KEVIN PAUL
33 granted patents·35 pending applications·685 citations·filing 1986–2023
98Inventor score
Files withSYNTA PHARMACEUTICALS CORP21ZYMOGENETICS INC8YING WEIWEN7RANOK THERAPEUTICS HANGZHOU CO LTD6BLACKMAN RONALD K5
Top patents by PatentIndex Score
68 records- 0198US8063083B2Method for treating non-Hodgkin's lymphomaFOLEY KEVIN·Filed 2007·Granted Nov 22, 2011·46 cites·11 claims
- 0298US8034834B2Method for treating proliferative disorders with HSP90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Oct 11, 2011·53 cites·15 claims
- 0397US8648104B2Method for treating proliferative disorders associated with mutations in c-MetDU ZHENJIAN·Filed 2008·Granted Feb 11, 2014·38 cites·8 claims
- 0497US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0596US8415377B2Triazole compounds that modulate HSP90 activitySUN LIJUN·Filed 2011·Granted Apr 9, 2013·40 cites·19 claims
- 0696US8318790B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted Nov 27, 2012·49 cites·68 claims
- 0796US7825148B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Nov 2, 2010·53 cites·51 claims
- 0895US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 0995US7608635B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Oct 27, 2009·32 cites·11 claims
- 1094US8629285B2Imidazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2006·Granted Jan 14, 2014·14 cites·17 claims
- 1194US8329736B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2012·Granted Dec 11, 2012·27 cites·14 claims
- 1294US8329899B2Pyrazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2011·Granted Dec 11, 2012·21 cites·12 claims
- 1394US8188075B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted May 29, 2012·36 cites·46 claims
- 1494US8183384B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2007·Granted May 22, 2012·26 cites·16 claims
- 1594US7662813B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 16, 2010·35 cites·35 claims
- 1693US8362055B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·25 cites·20 claims
- 1791US8969396B2Method for treating a B-raf associated cancer with an Hsp90 inhibitorDU ZHENJIAN·Filed 2011·Granted Mar 3, 2015·7 cites·4 claims
- 1888US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 1988US8927548B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2012·Granted Jan 6, 2015·10 cites·9 claims
- 2087US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 2187US8921407B2Pyrazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Dec 30, 2014·7 cites·15 claims
- 2286US8901308B2Triazole compounds that modulate Hsp90 activityYING WEIWEN·Filed 2012·Granted Dec 2, 2014·7 cites·2 claims
- 2386US8524712B2Triazinone and diazinone derivatives useful as HSP90 inhibitorsLEE CHI-WAN·Filed 2008·Granted Sep 3, 2013·15 cites·8 claims
- 2485US9090569B2Triazone compounds that modulate HSP90 activityYING WEIWEN·Filed 2009·Granted Jul 28, 2015·5 cites·19 claims
- 2584US9108933B2Method for treating proliferative disorders associated with mutations in c-MetDU ZHENJIAN·Filed 2014·Granted Aug 18, 2015·3 cites·4 claims
- 2682US9156794B2Imidazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Oct 13, 2015·4 cites·13 claims
- 2781US8269017B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2010·Granted Sep 18, 2012·4 cites·20 claims
- 2878US7884094B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 8, 2011·2 cites·8 claims
- 2977US9101614B2Method for treating non-Hodgkin's lymphomaFOLEY KEVIN·Filed 2011·Granted Aug 11, 2015·3 cites·6 claims
- 3075US9205086B2Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitorBLACKMAN RONALD K·Filed 2011·Granted Dec 8, 2015·3 cites·3 claims
- 3171US2007042465A1Mammalian transforming growth factor beta-9ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3271US2007042472A1Mammalian transforming growth factor beta-9ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3370US2015094349A1Method for Treating Proliferative Disorders Associated with Protooncogene ProductsSYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 3468US2010069442A1Pyrazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3567US2004132136A1Mammalian Transforming growth factor beta-9ZYMOGENETICS INC·Filed 2003·Application pending·0 cites
- 3665US2007043211A1Mammalian transforming growth factor beta-9ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3764US2007049740A1Mammalian transforming growth factor beta-9ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3864US2007048827A1Mammalian transforming growth factor beta-9ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3962US2007032493A1Method for treating B cell regulated autoimmune disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 4060US9090603B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Jul 28, 2015·0 cites·14 claims
- 4160US2015174132A1Method for treating b cell regulated autoimmune disordersSYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 4259US8598366B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2012·Granted Dec 3, 2013·0 cites·10 claims
- 4359US2015183771A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 4457US2024116950A1Inhibitors of kras(g12d)RANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2023·Application pending·0 cites
- 4556US2007280936A1Method for treating psoriasisZYMOGENETICS INC·Filed 2007·Application pending·0 cites
- 4656US2023365595A1Inhibitors of kras(g12d)RANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2023·Application pending·0 cites
- 4756US2016000756A1Imidazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 4856US2012021434A1Method for treating b cell regulated autoimmune disordersFOLEY KEVIN·Filed 2011·Application pending·0 cites
- 4955US2007048318A1Method for treating psoriasisZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 5053US2013072461A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin Foley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →